ÐÓ°ÉÔ­´´

CorWave, based in Paris, is set to make significant advancements in the healthcare sector with its advanced heart pumps for patients with severe heart conditions. By focusing on innovative technology, CorWave aims to provide better patient outcomes and increased reliability compared to traditional heart pumps, medications, or heart transplants. Their B2B model leverages strong backing from investors like Bpifrance, Sofinnova Partners, and Ysios Capital. With the potential to reduce mortality rates, enhance quality of life, and lower overall healthcare costs, CorWave could become a key player in the health tech industry.